Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma
Jérôme Verine, Jacqueline Lehmann-Che, Hany Soliman et al. · 2010
Read Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma by Jérôme Verine, Jacqueline Lehmann-Che, Hany Soliman et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010421.txt.
Description
Jérôme Verine and colleagues tested a possible marker for a common kidney cancer in PLOS ONE in 2010. Clear cell renal cancer is the most frequent type of kidney tumor. No specific marker existed to detect or track it. The team had earlier found a gene, angptl4, switched on strongly in these tumors. It responds to low oxygen, a common tumor condition. They asked whether its message RNA could serve as the marker.
A good marker should flag both first tumors and spread ones. It should also appear in samples doctors can actually take. Testing the RNA in patient material was the next step this study took. Kidney cancer found early is far more curable. A reliable marker would change how it is watched and treated.
Catalog record
| CREATOR | Jérôme Verine, Jacqueline Lehmann-Che, Hany Soliman et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010421